IRLAB Therapeutics AB (publ) Cash Flow Reinvestment Rate

Latest as of September 2025: 0.00x

IRLAB Therapeutics AB (publ) cash flow reinvestment rate. IRLAB Therapeutics AB (publ) (IRLAB-A) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr5.26 Million. Explore IRLAB-A operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

Skr0.00

Capex + Investments

Operating Cash Flow

Skr5.26 Million

SEK

Capital Expenditures

Skr0.00

SEK

Cash Flow Reinvestment Rate of IRLAB Therapeutics AB (publ) (2021–2021)

Cash flow reinvestment rate of IRLAB Therapeutics AB (publ) from 2021 to 2021. Historical reinvestment intensity for IRLAB Therapeutics AB (publ) across 1 annual periods. Explore IRLAB Therapeutics AB (publ) (IRLAB-A) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

IRLAB Therapeutics AB (publ) Cash Flow Reinvestment Rate by Year (2021–2021)

IRLAB Therapeutics AB (publ) cash flow reinvestment rate by year from 2021 to 2021. Year-by-year capital reinvestment analysis for IRLAB Therapeutics AB (publ). For the full cash flow conversion analysis, see cash flow conversion of IRLAB Therapeutics AB (publ).

Year	Reinvestment Rate	Total Reinvested (SEK)	Operating CF	Capex	YoY Change
2021	0.01x	Skr1.42 Million	Skr128.64 Million	Skr708.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow